Pomdoctor(NASDAQ) POM

Market Cap$25.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-99%
5 YearN/A
1 Year-99%
1 Month+13%
$1.80
-18.77%
-0.42Today
Pre market$2.28+$0.48 (+26.67%)
Pomdoctor last closing stock price
MetricPriceDate
Last closeUSD 3.012026-10-21
Pomdoctor stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+40.46%USD 2.142026-10-14
1 month+12.87%USD 2.672026-09-21
3 month+26.45%USD 2.382026-07-23
Year to date-82.99%USD 17.692025-12-31
1 year-98.83%USD 258.002025-10-21
Since inception-99.08%USD 72.542025-10-08

Pomdoctor Financials at a Glance

Market Cap

$25.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥345.02M

Net Income (TTM)

-CN¥288.80M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.83 (Low)

Price

$1.80

Volume

3,743,554.768

Open

$0.95

Previous Close

$3.01

Daily Range

$0.69 - $3.01

52-Week Range

$0.69 - $385.80

Estimated Earnings Date

Aug 13, 2026

POM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pomdoctor

POMDOCTOR Ltd is a healthcare company focused on providing an e-commerce platform for pharmaceutical products and online healthcare services in China. The company specializes in chronic disease management, connecting patients with medical professionals and essential medications through a digital portal.

Products and Services
  • E-commerce platform for direct pharmaceutical sales
  • Online healthcare services for chronic disease management
  • Virtual hospital model linking patients and healthcare providers
Growth Outlook
  • Expansion into the Chinese healthcare market is underway
  • Increasing demand for online healthcare services is evident
  • Focus on chronic disease care aligns with market needs
Financial Highlights
  • Recent quarterly revenue of 27,069,990 CNY shows potential growth
  • Trailing twelve months (TTM) revenue of 92,500,130 CNY indicates strong sales
  • Operating expenses reflect significant investment in R&D and marketing
POMDOCTOR Ltd operates in the medical and pharmaceutical industry, leveraging technology to enhance healthcare delivery. The company's innovative approach to chronic disease management positions it well within a growing market. Recent financial data indicates a revenue increase, suggesting a positive trajectory. The focus on e-commerce and online healthcare services aligns with current trends, making POMDOCTOR a noteworthy entity in the healthcare sector.
AI Generated • Oct 21, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

165

CEO

Zhen Yang Shi, EMBA

Website

www.7lk.com

Headquarters

Guangzhou, GD 510000, CN

POM Financials

Key Financial Metrics (TTM)

Gross Margin

11.68%

Operating Margin

-74.18%

Net Income Margin

-83.71%

Return on Equity

79.79%

Return on Capital

-12014.22%

Return on Assets

-2573.37%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.59M

Volume

3.74M

Avg. Volume

770.24K

Financials (TTM)

Gross Profit

CN¥40.30M

Operating Income

-CN¥255.92M

EBITDA

-CN¥255.47M

Operating Cash Flow

-CN¥126.98M

Capital Expenditure

-CN¥1.79M

Free Cash Flow

-CN¥128.77M

Cash & ST Invst.

CN¥1.86M

Total Debt

CN¥66.36M

Pomdoctor Performance Analysis

Pomdoctor annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 36,416,2669.0%
20232023-12-31CNY 43,027,76918.2%
20242024-12-31CNY 47,598,52810.6%
20252025-12-31CNY 55,633,00516.9%
Pomdoctor sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3029.2%
Q42025-12-31N/A
Q12026-03-31-17.9%
Q22026-06-30-70.7%
Pomdoctor annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY -2.83-36.2%
20232023-12-31CNY -3.1210.1%
20242024-12-31CNY -3.03-2.9%
20252025-12-31CNY -91.642927.3%
Pomdoctor sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-306.2%
Q42025-12-31N/A
Q12026-03-317.8%
Q22026-06-3070.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥27.07M

-69.0%

Gross Profit

CN¥3.70M

-73.9%

Gross Margin

13.66%

N/A

Market Cap

$25.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$156.65K

N/A

Employees

165

N/A

Net Income

-CN¥33.62M

+7.0%

EBITDA

-CN¥34.06M

-500.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥1.86M

-67.7%

Total Debt

CN¥66.36M

-85.4%

Accounts Receivable

CN¥8.08M

-58.3%

Inventory

CN¥937.56K

-85.5%

Long Term Debt

CN¥54.75M

-85.0%

Short Term Debt

CN¥11.61M

-87.3%

Return on Assets

-25.73%

N/A

Return on Invested Capital

12.88%

N/A

Free Cash Flow

CN¥1.45M

+118.8%

Operating Cash Flow

CN¥1.47M

+119.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIRSAirSculpt Technologies, Inc.
$1.28-1.54%
AVXLAnavex Life Sciences Corp.
$1.36+0.00%
OFIXOrthofix Medical Inc.
$9.74-1.12%
AQSTAquestive Therapeutics, Inc.
$4.08+0.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$103.24+5.83%
SPCXSpace Exploration Technologies
$159.31+7.80%
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$11.94+5.29%
NOKNokia
$9.25+2.55%

Questions About POM

What is the current price of Pomdoctor?

Pomdoctor is trading at $3.01 per share.

What is the 52-week range for Pomdoctor?

Over the past 52 weeks, Pomdoctor has traded between $0.69 and $385.80.

How much debt does Pomdoctor have?

As of the most recent reporting period, Pomdoctor reported total debt of CN¥65.10M.

How much cash does Pomdoctor have on hand?

Pomdoctor reported CN¥1.37M in cash and cash equivalents in its most recent financial results.

What is Pomdoctor’s dividend yield?

Pomdoctor does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services